Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Comparing Acetaminophen, NSAIDs, and Trypsin-Chymotrypsin + Acetaminophen on Post-Endodontic Pain
NCT07759349Phase 1Recruiting
- Sponsor
- Dow University of Health Sciences
- Start
- Aug 2026
- Primary completion
- Dec 2026
- Countries
- 1
01
Overview
Phase 1, randomised, single-blind trial of trypsin + chymotrypsin in irreversible pulpitis (3 arms), sponsored by Dow University of Health Sciences. Primary endpoint: Visual Analog Scale for Post-Endodontic Pain at 72 hours. Started Aug 2026; status: recruiting.
02
Drugs
trypsin + chymotrypsin
03
Conditions
irreversible pulpitis
Beyond the preview
Go deeper on NCT07759349.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT07759349.